Non-small Cell Lung Cancer
📧 Sign up to get email alerts when something new happens for Non-small Cell Lung Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2013-10-25Clinical Trial Update: Chemotherapy of Elderly Patients With Non-Small-Cell Lung Cancer (NSCLC) [Phase 3]
Phase 3 trial evaluating chemotherapy in elderly patients with non-small cell lung cancer has completed.
-
CLINICAL_TRIALS trial_result · 2013-10-25Clinical Trial Update: EMD 273066 in Patients With Recurrent EpCAM Positive Ovarian, Prostate, Colorectal or Non-small Cell Lung Cancers When First Given Cyclophosphamide [Phase 1]
Phase 1 trial evaluating EMD 273066 in EpCAM-positive recurrent ovarian, prostate, colorectal, or non-small cell lung cancer when first trea…
-
CLINICAL_TRIALS trial_result · 2013-10-23Clinical Trial Update: Single-arm Trial of BIBW 2992 (Afatinib) in Demographically and Genotypically Selected NSCLC Patients [Phase 2]
A single-arm Phase 2 trial of afatinib (BIBW 2992) in demographically and genotypically selected non-small cell lung cancer patients has com…
-
CLINICAL_TRIALS trial_result · 2013-10-23Clinical Trial Update: IPI-504 in NSCLC Patients With ALK Translocations [Phase 2]
Phase 2 study of IPI-504 (retaspimycin hydrochloride) in ALK-translocated non-small cell lung cancer was terminated; results were posted in …
-
CLINICAL_TRIALS trial_result · 2013-10-23Clinical Trial Update: Sirolimus and Pemetrexed to Treat Non-Small Cell Lung Cancer [Phase 1, Phase 2]
A clinical trial investigating sirolimus plus pemetrexed for non-small cell lung cancer was terminated after Phase 1/Phase 2, with results p…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2013-10-22Clinical Trial Update: Safety of Adding IMO-2055 to Erlotinib + Bevacizumab in 2nd Line Treatment for Patients With NSCLC [Phase 1]
A Phase 1 study evaluating the safety of adding IMO-2055 to erlotinib plus bevacizumab in second-line non-small cell lung cancer.
-
CLINICAL_TRIALS trial_result · 2013-10-17Clinical Trial Update: A Phase II Trial of Afatinib(BIBW 2992) in Third-line Treatment for Patients With Stage IIIB/IV Adenocarcinoma of the Lung Harbouring Wild-type Epidermal Growth Factor Receptor[EGFR] [Phase 2]
Phase II trial evaluating afatinib (BIBW 2992) as third-line therapy for patients with stage IIIB/IV non-small cell lung cancer with wild-ty…
-
CLINICAL_TRIALS trial_result · 2013-10-17Clinical Trial Update: BIBW2992 (Afatinib) in Advanced (EGFR-FISH +) NSCLC (Non Small Cell Lung Cancer) Patients [Phase 2]
Phase 2 trial of afatinib (BIBW2992) in advanced EGFR-FISH positive non-small cell lung cancer has completed. Results have been posted.
-
CLINICAL_TRIALS trial_result · 2013-10-17Clinical Trial Update: The Effects of AZD2171 in Patients With Non-Small Cell Lung Cancer or Head & Neck Cancer [Phase 1]
Phase 1 trial of cediranib (AZD2171) in patients with non-small cell lung cancer and head and neck cancer has completed, with results posted…
-
CLINICAL_TRIALS trial_result · 2013-10-14Clinical Trial Update: LUX Lung 2 Phase II Single Arm BIBW 2992 "Afatinib" in NSCLC With EGFR Activating Mutations [Phase 2]
Phase II single-arm trial evaluating afatinib (BIBW 2992) in non-small cell lung cancer with EGFR activating mutations; study completed and …
-
CLINICAL_TRIALS trial_result · 2013-10-14Clinical Trial Update: Efficacy, Safety, Tolerability of Gefitinib as 1st Line in Caucasian Patients With EGFR Mutation Positive Advanced NSCLC [Phase 4]
Phase 4 trial update evaluating gefitinib as first-line therapy in Caucasian patients with EGFR mutation-positive advanced non-small cell lu…
-
CLINICAL_TRIALS trial_result · 2013-10-11Clinical Trial Update: Phase 2b Study of Cetuximab With Platinum-Based Chemo as First Line Treatment of Recurrent or Advanced NSCLC [Phase 2]
Phase 2b study evaluating cetuximab with platinum-based chemotherapy as first-line treatment for recurrent or advanced non-small cell lung c…
-
CLINICAL_TRIALS withdrawal · 2013-10-11Clinical Trial Update: TS Stratified Chemotherapy and VEGF Inhibition in Non-Squamous Non-Small Cell Lung Cancer - Stage IV [Phase 2]
A Phase 2 trial evaluating TS-stratified chemotherapy with VEGF inhibition for stage IV non-squamous non-small cell lung cancer has been wit…
-
CLINICAL_TRIALS trial_result · 2013-10-08Clinical Trial Update: Comprehensive Geriatric Assessment and Complications Following Lung Resection for Lung Cancer
This ClinicalTrials.gov entry notes the completed status of a study evaluating comprehensive geriatric assessment and postoperative complica…
-
FDA approval · 2013-10-07FDA Approved: XALKORI — Supplemental Application (Pfizer Laboratories Div Pfizer Inc)
FDA approved a supplemental application for XALKORI (crizotinib) from Pfizer, expanding its labeled indications.
-
CLINICAL_TRIALS trial_result · 2013-10-01Clinical Trial Update: Elderly Independent Patients With Non Small Cell Lung Cancer (NSCLC)
Clinical trial NCT00418704, investigating elderly independent patients with non-small cell lung cancer, has completed.
-
CLINICAL_TRIALS trial_result · 2013-10-01Clinical Trial Update: Study to Assess Safety/Tolerability/Efficacy of Gefitinib Versus Docetaxel in Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC) [Phase 4]
A Phase 4 trial comparing gefitinib vs. docetaxel in locally advanced or metastatic non-small cell lung cancer was terminated, with results …
-
CLINICAL_TRIALS trial_result · 2013-10-01Clinical Trial Update: Elderly Dependent Patients With Non Small Cell Lung Cancer (NSCLC)
Clinical trial update indicating completion of a study involving elderly dependent patients with non-small cell lung cancer.
-
CLINICAL_TRIALS trial_result · 2013-09-30Clinical Trial Update: 7-Hydroxystaurosporine and Irinotecan Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors or Triple Negative Breast Cancer (Currently Accruing Only Triple-negative Breast Cancer Patients Since 6/8/2007) [Phase 1]
This Phase 1 clinical trial update evaluates the combination of 7-Hydroxystaurosporine and Irinotecan Hydrochloride in patients with metasta…
-
CLINICAL_TRIALS trial_result · 2013-09-30Clinical Trial Update: Decitabine and Valproic Acid in Treating Patients With Non-Small Cell Lung Cancer [Phase 1]
Phase 1 trial evaluating decitabine in combination with valproic acid for recurrent or stage IV non-small cell lung cancer; study completed.
-
CLINICAL_TRIALS trial_result · 2013-09-25Clinical Trial Update: A Study of Dasatinib With Concurrent Chemoradiation for Stage III Non-Small Cell Lung Cancer (NSCLC) [Phase 1]
Phase 1 study of dasatinib with concurrent chemoradiation for stage III non-small cell lung cancer was terminated, with results posted in 20…
-
CLINICAL_TRIALS trial_result · 2013-09-24Clinical Trial Update: SAR240550 in Combination With Gemcitabine/Cisplatin in Non-small Cell Lung Cancer [Phase 2]
Sanofi’s Phase 2 trial of SAR240550 in combination with gemcitabine and cisplatin for non-small cell lung cancer has completed.
-
CLINICAL_TRIALS trial_result · 2013-09-20Clinical Trial Update: Hospitalization Rates of Patients With Non-Small Cell Lung Cancer Treated With Gemcitabine and Either Cisplatin or Carboplatin [Phase 3]
Phase 3 trial comparing gemcitabine with cisplatin versus gemcitabine with carboplatin in non-small cell lung cancer reports hospitalization…
-
CLINICAL_TRIALS trial_result · 2013-09-20Clinical Trial Update: Combination Chemotherapy in Treating Patients With Stage I, II, or IIIA Non-small Cell Lung Cancer That Has Been Surgically Removed [Phase 3]
Phase 3 trial update on combination chemotherapy for patients with surgically removed stage I to IIIA non-small cell lung cancer. The curren…
-
CLINICAL_TRIALS research · 2013-09-20Clinical Trial Update: Gemcitabine Plus Supportive Care in Treating Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer [Phase 2, Phase 3]
Clinical trial update on gemcitabine plus supportive care for locally advanced or metastatic non-small cell lung cancer, covering Phase 2 an…